nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—NR1I2—Docetaxel—stomach cancer	0.643	0.891	CbGbCtD
Rifaximin—CYP3A4—Irinotecan—stomach cancer	0.0344	0.0477	CbGbCtD
Rifaximin—CYP3A4—Docetaxel—stomach cancer	0.0252	0.0349	CbGbCtD
Rifaximin—CYP3A4—Doxorubicin—stomach cancer	0.0188	0.026	CbGbCtD
Rifaximin—NR1I2—Nuclear Receptors—RXRB—stomach cancer	0.00195	0.0902	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—RORA—stomach cancer	0.00158	0.073	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.00154	0.0713	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—RXRB—stomach cancer	0.00154	0.0713	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—RARB—stomach cancer	0.00141	0.0652	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—RORA—stomach cancer	0.00125	0.0577	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—RARB—stomach cancer	0.00112	0.0516	CbGpPWpGaD
Rifaximin—Rifampicin—CYP2A6—stomach cancer	0.000877	1	CrCbGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ZNF559—stomach cancer	0.000669	0.0309	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000597	0.0276	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARG—stomach cancer	0.000546	0.0253	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ZNF160—stomach cancer	0.000507	0.0235	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARG—stomach cancer	0.000432	0.02	CbGpPWpGaD
Rifaximin—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	0.000421	0.0195	CbGpPWpGaD
Rifaximin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	0.000341	0.0158	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ZNF559—stomach cancer	0.000322	0.0149	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.000318	0.0147	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PRPF19—stomach cancer	0.000274	0.0127	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	0.000273	0.0126	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—RXRB—stomach cancer	0.000266	0.0123	CbGpPWpGaD
Rifaximin—Hyperglycaemia—Doxorubicin—stomach cancer	0.000259	0.00101	CcSEcCtD
Rifaximin—Diarrhoea—Irinotecan—stomach cancer	0.000259	0.00101	CcSEcCtD
Rifaximin—Dry mouth—Capecitabine—stomach cancer	0.000258	0.00101	CcSEcCtD
Rifaximin—Pneumonia—Doxorubicin—stomach cancer	0.000257	0.001	CcSEcCtD
Rifaximin—Shock—Docetaxel—stomach cancer	0.000257	0.001	CcSEcCtD
Rifaximin—Nervous system disorder—Docetaxel—stomach cancer	0.000256	0.001	CcSEcCtD
Rifaximin—Pruritus—Fluorouracil—stomach cancer	0.000256	0.000999	CcSEcCtD
Rifaximin—Infestation NOS—Doxorubicin—stomach cancer	0.000256	0.000998	CcSEcCtD
Rifaximin—Infestation—Doxorubicin—stomach cancer	0.000256	0.000998	CcSEcCtD
Rifaximin—Confusional state—Capecitabine—stomach cancer	0.000255	0.000995	CcSEcCtD
Rifaximin—Skin disorder—Docetaxel—stomach cancer	0.000254	0.00099	CcSEcCtD
Rifaximin—Infection—Capecitabine—stomach cancer	0.000251	0.000981	CcSEcCtD
Rifaximin—Dizziness—Irinotecan—stomach cancer	0.00025	0.000975	CcSEcCtD
Rifaximin—Haemoglobin—Epirubicin—stomach cancer	0.000249	0.000973	CcSEcCtD
Rifaximin—Anorexia—Docetaxel—stomach cancer	0.000249	0.000972	CcSEcCtD
Rifaximin—Shock—Capecitabine—stomach cancer	0.000249	0.000971	CcSEcCtD
Rifaximin—Rhinitis—Epirubicin—stomach cancer	0.000249	0.00097	CcSEcCtD
Rifaximin—Nervous system disorder—Capecitabine—stomach cancer	0.000248	0.000968	CcSEcCtD
Rifaximin—Haemorrhage—Epirubicin—stomach cancer	0.000248	0.000968	CcSEcCtD
Rifaximin—Diarrhoea—Fluorouracil—stomach cancer	0.000248	0.000967	CcSEcCtD
Rifaximin—Tinnitus—Methotrexate—stomach cancer	0.000247	0.000964	CcSEcCtD
Rifaximin—Hypoaesthesia—Epirubicin—stomach cancer	0.000247	0.000963	CcSEcCtD
Rifaximin—Pharyngitis—Epirubicin—stomach cancer	0.000246	0.000961	CcSEcCtD
Rifaximin—Skin disorder—Capecitabine—stomach cancer	0.000246	0.000959	CcSEcCtD
Rifaximin—Urinary tract disorder—Epirubicin—stomach cancer	0.000245	0.000956	CcSEcCtD
Rifaximin—Hyperhidrosis—Capecitabine—stomach cancer	0.000245	0.000954	CcSEcCtD
Rifaximin—Oedema peripheral—Epirubicin—stomach cancer	0.000244	0.000954	CcSEcCtD
Rifaximin—Hypotension—Docetaxel—stomach cancer	0.000244	0.000953	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—ZNF160—stomach cancer	0.000244	0.0113	CbGpPWpGaD
Rifaximin—Haematuria—Doxorubicin—stomach cancer	0.000244	0.000951	CcSEcCtD
Rifaximin—Urethral disorder—Epirubicin—stomach cancer	0.000243	0.000949	CcSEcCtD
Rifaximin—Epistaxis—Doxorubicin—stomach cancer	0.000241	0.000941	CcSEcCtD
Rifaximin—Anorexia—Capecitabine—stomach cancer	0.000241	0.000941	CcSEcCtD
Rifaximin—Angiopathy—Methotrexate—stomach cancer	0.000241	0.000938	CcSEcCtD
Rifaximin—Vomiting—Irinotecan—stomach cancer	0.00024	0.000938	CcSEcCtD
Rifaximin—Dizziness—Fluorouracil—stomach cancer	0.00024	0.000934	CcSEcCtD
Rifaximin—Mediastinal disorder—Methotrexate—stomach cancer	0.000239	0.000932	CcSEcCtD
Rifaximin—Rash—Irinotecan—stomach cancer	0.000238	0.00093	CcSEcCtD
Rifaximin—Dermatitis—Irinotecan—stomach cancer	0.000238	0.000929	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000238	0.000929	CcSEcCtD
Rifaximin—Headache—Irinotecan—stomach cancer	0.000237	0.000924	CcSEcCtD
Rifaximin—Hypotension—Capecitabine—stomach cancer	0.000237	0.000922	CcSEcCtD
Rifaximin—Insomnia—Docetaxel—stomach cancer	0.000236	0.000922	CcSEcCtD
Rifaximin—Dyspnoea—Docetaxel—stomach cancer	0.000233	0.000909	CcSEcCtD
Rifaximin—Mental disorder—Methotrexate—stomach cancer	0.000232	0.000906	CcSEcCtD
Rifaximin—Tinnitus—Epirubicin—stomach cancer	0.000231	0.000903	CcSEcCtD
Rifaximin—Malnutrition—Methotrexate—stomach cancer	0.000231	0.0009	CcSEcCtD
Rifaximin—Haemoglobin—Doxorubicin—stomach cancer	0.000231	0.0009	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000231	0.000899	CcSEcCtD
Rifaximin—Flushing—Epirubicin—stomach cancer	0.00023	0.000898	CcSEcCtD
Rifaximin—Vomiting—Fluorouracil—stomach cancer	0.00023	0.000898	CcSEcCtD
Rifaximin—Rhinitis—Doxorubicin—stomach cancer	0.00023	0.000898	CcSEcCtD
Rifaximin—Haemorrhage—Doxorubicin—stomach cancer	0.00023	0.000896	CcSEcCtD
Rifaximin—Insomnia—Capecitabine—stomach cancer	0.000229	0.000893	CcSEcCtD
Rifaximin—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	0.000229	0.0106	CbGpPWpGaD
Rifaximin—Hypoaesthesia—Doxorubicin—stomach cancer	0.000228	0.000891	CcSEcCtD
Rifaximin—Rash—Fluorouracil—stomach cancer	0.000228	0.000891	CcSEcCtD
Rifaximin—Dermatitis—Fluorouracil—stomach cancer	0.000228	0.00089	CcSEcCtD
Rifaximin—Pharyngitis—Doxorubicin—stomach cancer	0.000228	0.000889	CcSEcCtD
Rifaximin—Decreased appetite—Docetaxel—stomach cancer	0.000227	0.000886	CcSEcCtD
Rifaximin—Headache—Fluorouracil—stomach cancer	0.000227	0.000885	CcSEcCtD
Rifaximin—Urinary tract disorder—Doxorubicin—stomach cancer	0.000227	0.000885	CcSEcCtD
Rifaximin—Oedema peripheral—Doxorubicin—stomach cancer	0.000226	0.000882	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000226	0.00088	CcSEcCtD
Rifaximin—Dyspnoea—Capecitabine—stomach cancer	0.000226	0.00088	CcSEcCtD
Rifaximin—Fatigue—Docetaxel—stomach cancer	0.000225	0.000879	CcSEcCtD
Rifaximin—Angiopathy—Epirubicin—stomach cancer	0.000225	0.000878	CcSEcCtD
Rifaximin—Urethral disorder—Doxorubicin—stomach cancer	0.000225	0.000878	CcSEcCtD
Rifaximin—Nausea—Irinotecan—stomach cancer	0.000225	0.000876	CcSEcCtD
Rifaximin—Mediastinal disorder—Epirubicin—stomach cancer	0.000224	0.000872	CcSEcCtD
Rifaximin—Pain—Docetaxel—stomach cancer	0.000224	0.000872	CcSEcCtD
Rifaximin—Constipation—Docetaxel—stomach cancer	0.000224	0.000872	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—EEF1A2—stomach cancer	0.000223	0.0103	CbGpPWpGaD
Rifaximin—Back pain—Methotrexate—stomach cancer	0.000223	0.000871	CcSEcCtD
Rifaximin—Decreased appetite—Capecitabine—stomach cancer	0.00022	0.000858	CcSEcCtD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	0.00022	0.0102	CbGpPWpGaD
Rifaximin—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000219	0.000852	CcSEcCtD
Rifaximin—Fatigue—Capecitabine—stomach cancer	0.000218	0.000851	CcSEcCtD
Rifaximin—Mental disorder—Epirubicin—stomach cancer	0.000217	0.000848	CcSEcCtD
Rifaximin—Constipation—Capecitabine—stomach cancer	0.000216	0.000844	CcSEcCtD
Rifaximin—Pain—Capecitabine—stomach cancer	0.000216	0.000844	CcSEcCtD
Rifaximin—Malnutrition—Epirubicin—stomach cancer	0.000216	0.000843	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—RORA—stomach cancer	0.000215	0.00996	CbGpPWpGaD
Rifaximin—Feeling abnormal—Docetaxel—stomach cancer	0.000215	0.00084	CcSEcCtD
Rifaximin—Nausea—Fluorouracil—stomach cancer	0.000215	0.000839	CcSEcCtD
Rifaximin—Ill-defined disorder—Methotrexate—stomach cancer	0.000214	0.000835	CcSEcCtD
Rifaximin—Tinnitus—Doxorubicin—stomach cancer	0.000214	0.000835	CcSEcCtD
Rifaximin—Gastrointestinal pain—Docetaxel—stomach cancer	0.000214	0.000834	CcSEcCtD
Rifaximin—Anaemia—Methotrexate—stomach cancer	0.000213	0.000832	CcSEcCtD
Rifaximin—Flushing—Doxorubicin—stomach cancer	0.000213	0.000831	CcSEcCtD
Rifaximin—Flatulence—Epirubicin—stomach cancer	0.000213	0.00083	CcSEcCtD
Rifaximin—Back pain—Epirubicin—stomach cancer	0.000209	0.000815	CcSEcCtD
Rifaximin—Feeling abnormal—Capecitabine—stomach cancer	0.000209	0.000813	CcSEcCtD
Rifaximin—Angiopathy—Doxorubicin—stomach cancer	0.000208	0.000813	CcSEcCtD
Rifaximin—Malaise—Methotrexate—stomach cancer	0.000208	0.000812	CcSEcCtD
Rifaximin—Muscle spasms—Epirubicin—stomach cancer	0.000208	0.00081	CcSEcCtD
Rifaximin—Vertigo—Methotrexate—stomach cancer	0.000207	0.000809	CcSEcCtD
Rifaximin—Gastrointestinal pain—Capecitabine—stomach cancer	0.000207	0.000807	CcSEcCtD
Rifaximin—Mediastinal disorder—Doxorubicin—stomach cancer	0.000207	0.000807	CcSEcCtD
Rifaximin—Abdominal pain—Docetaxel—stomach cancer	0.000207	0.000806	CcSEcCtD
Rifaximin—Body temperature increased—Docetaxel—stomach cancer	0.000207	0.000806	CcSEcCtD
Rifaximin—Cough—Methotrexate—stomach cancer	0.000201	0.000786	CcSEcCtD
Rifaximin—Mental disorder—Doxorubicin—stomach cancer	0.000201	0.000785	CcSEcCtD
Rifaximin—Urticaria—Capecitabine—stomach cancer	0.000201	0.000784	CcSEcCtD
Rifaximin—Ill-defined disorder—Epirubicin—stomach cancer	0.0002	0.000782	CcSEcCtD
Rifaximin—Abdominal pain—Capecitabine—stomach cancer	0.0002	0.00078	CcSEcCtD
Rifaximin—Body temperature increased—Capecitabine—stomach cancer	0.0002	0.00078	CcSEcCtD
Rifaximin—Malnutrition—Doxorubicin—stomach cancer	0.0002	0.00078	CcSEcCtD
Rifaximin—Anaemia—Epirubicin—stomach cancer	0.0002	0.000779	CcSEcCtD
Rifaximin—Flatulence—Doxorubicin—stomach cancer	0.000197	0.000768	CcSEcCtD
Rifaximin—Myalgia—Methotrexate—stomach cancer	0.000197	0.000767	CcSEcCtD
Rifaximin—Arthralgia—Methotrexate—stomach cancer	0.000197	0.000767	CcSEcCtD
Rifaximin—Chest pain—Methotrexate—stomach cancer	0.000197	0.000767	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000195	0.000761	CcSEcCtD
Rifaximin—Malaise—Epirubicin—stomach cancer	0.000195	0.00076	CcSEcCtD
Rifaximin—Discomfort—Methotrexate—stomach cancer	0.000194	0.000757	CcSEcCtD
Rifaximin—Vertigo—Epirubicin—stomach cancer	0.000194	0.000757	CcSEcCtD
Rifaximin—Syncope—Epirubicin—stomach cancer	0.000194	0.000756	CcSEcCtD
Rifaximin—Back pain—Doxorubicin—stomach cancer	0.000193	0.000754	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—RARB—stomach cancer	0.000193	0.00891	CbGpPWpGaD
Rifaximin—Hypersensitivity—Docetaxel—stomach cancer	0.000193	0.000751	CcSEcCtD
Rifaximin—Muscle spasms—Doxorubicin—stomach cancer	0.000192	0.00075	CcSEcCtD
Rifaximin—Confusional state—Methotrexate—stomach cancer	0.00019	0.000741	CcSEcCtD
Rifaximin—Loss of consciousness—Epirubicin—stomach cancer	0.00019	0.000741	CcSEcCtD
Rifaximin—Cough—Epirubicin—stomach cancer	0.000189	0.000735	CcSEcCtD
Rifaximin—Anaphylactic shock—Methotrexate—stomach cancer	0.000188	0.000735	CcSEcCtD
Rifaximin—Asthenia—Docetaxel—stomach cancer	0.000188	0.000732	CcSEcCtD
Rifaximin—Infection—Methotrexate—stomach cancer	0.000187	0.00073	CcSEcCtD
Rifaximin—Hypersensitivity—Capecitabine—stomach cancer	0.000186	0.000727	CcSEcCtD
Rifaximin—Ill-defined disorder—Doxorubicin—stomach cancer	0.000185	0.000723	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—HNRNPL—stomach cancer	0.000185	0.00856	CbGpPWpGaD
Rifaximin—Pruritus—Docetaxel—stomach cancer	0.000185	0.000721	CcSEcCtD
Rifaximin—Nervous system disorder—Methotrexate—stomach cancer	0.000185	0.000721	CcSEcCtD
Rifaximin—Anaemia—Doxorubicin—stomach cancer	0.000185	0.000721	CcSEcCtD
Rifaximin—Arthralgia—Epirubicin—stomach cancer	0.000184	0.000717	CcSEcCtD
Rifaximin—Myalgia—Epirubicin—stomach cancer	0.000184	0.000717	CcSEcCtD
Rifaximin—Chest pain—Epirubicin—stomach cancer	0.000184	0.000717	CcSEcCtD
Rifaximin—Skin disorder—Methotrexate—stomach cancer	0.000183	0.000714	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000183	0.000712	CcSEcCtD
Rifaximin—Hyperhidrosis—Methotrexate—stomach cancer	0.000182	0.00071	CcSEcCtD
Rifaximin—Discomfort—Epirubicin—stomach cancer	0.000182	0.000709	CcSEcCtD
Rifaximin—Asthenia—Capecitabine—stomach cancer	0.000182	0.000708	CcSEcCtD
Rifaximin—Malaise—Doxorubicin—stomach cancer	0.00018	0.000703	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	0.00018	0.00833	CbGpPWpGaD
Rifaximin—Dry mouth—Epirubicin—stomach cancer	0.00018	0.000702	CcSEcCtD
Rifaximin—Vertigo—Doxorubicin—stomach cancer	0.00018	0.000701	CcSEcCtD
Rifaximin—Anorexia—Methotrexate—stomach cancer	0.00018	0.0007	CcSEcCtD
Rifaximin—Syncope—Doxorubicin—stomach cancer	0.000179	0.000699	CcSEcCtD
Rifaximin—Pruritus—Capecitabine—stomach cancer	0.000179	0.000698	CcSEcCtD
Rifaximin—Diarrhoea—Docetaxel—stomach cancer	0.000179	0.000698	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000178	0.00825	CbGpPWpGaD
Rifaximin—Confusional state—Epirubicin—stomach cancer	0.000178	0.000693	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—EEF1A1—stomach cancer	0.000177	0.00816	CbGpPWpGaD
Rifaximin—Anaphylactic shock—Epirubicin—stomach cancer	0.000176	0.000688	CcSEcCtD
Rifaximin—Hypotension—Methotrexate—stomach cancer	0.000176	0.000687	CcSEcCtD
Rifaximin—Loss of consciousness—Doxorubicin—stomach cancer	0.000176	0.000685	CcSEcCtD
Rifaximin—Infection—Epirubicin—stomach cancer	0.000175	0.000683	CcSEcCtD
Rifaximin—Cough—Doxorubicin—stomach cancer	0.000174	0.00068	CcSEcCtD
Rifaximin—Shock—Epirubicin—stomach cancer	0.000173	0.000677	CcSEcCtD
Rifaximin—Diarrhoea—Capecitabine—stomach cancer	0.000173	0.000675	CcSEcCtD
Rifaximin—Nervous system disorder—Epirubicin—stomach cancer	0.000173	0.000674	CcSEcCtD
Rifaximin—Dizziness—Docetaxel—stomach cancer	0.000173	0.000674	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000172	0.00067	CcSEcCtD
Rifaximin—Skin disorder—Epirubicin—stomach cancer	0.000171	0.000668	CcSEcCtD
Rifaximin—Hyperhidrosis—Epirubicin—stomach cancer	0.00017	0.000665	CcSEcCtD
Rifaximin—Insomnia—Methotrexate—stomach cancer	0.00017	0.000665	CcSEcCtD
Rifaximin—Arthralgia—Doxorubicin—stomach cancer	0.00017	0.000664	CcSEcCtD
Rifaximin—Chest pain—Doxorubicin—stomach cancer	0.00017	0.000664	CcSEcCtD
Rifaximin—Myalgia—Doxorubicin—stomach cancer	0.00017	0.000664	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000169	0.000659	CcSEcCtD
Rifaximin—Discomfort—Doxorubicin—stomach cancer	0.000168	0.000656	CcSEcCtD
Rifaximin—Anorexia—Epirubicin—stomach cancer	0.000168	0.000656	CcSEcCtD
Rifaximin—Dyspnoea—Methotrexate—stomach cancer	0.000168	0.000655	CcSEcCtD
Rifaximin—Dizziness—Capecitabine—stomach cancer	0.000167	0.000653	CcSEcCtD
Rifaximin—Dry mouth—Doxorubicin—stomach cancer	0.000166	0.000649	CcSEcCtD
Rifaximin—Vomiting—Docetaxel—stomach cancer	0.000166	0.000648	CcSEcCtD
Rifaximin—Rash—Docetaxel—stomach cancer	0.000165	0.000643	CcSEcCtD
Rifaximin—Hypotension—Epirubicin—stomach cancer	0.000165	0.000643	CcSEcCtD
Rifaximin—Dermatitis—Docetaxel—stomach cancer	0.000165	0.000642	CcSEcCtD
Rifaximin—Confusional state—Doxorubicin—stomach cancer	0.000165	0.000642	CcSEcCtD
Rifaximin—Decreased appetite—Methotrexate—stomach cancer	0.000164	0.000639	CcSEcCtD
Rifaximin—Headache—Docetaxel—stomach cancer	0.000164	0.000639	CcSEcCtD
Rifaximin—Anaphylactic shock—Doxorubicin—stomach cancer	0.000163	0.000636	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000163	0.000634	CcSEcCtD
Rifaximin—Fatigue—Methotrexate—stomach cancer	0.000162	0.000634	CcSEcCtD
Rifaximin—Infection—Doxorubicin—stomach cancer	0.000162	0.000632	CcSEcCtD
Rifaximin—Pain—Methotrexate—stomach cancer	0.000161	0.000628	CcSEcCtD
Rifaximin—Vomiting—Capecitabine—stomach cancer	0.000161	0.000628	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000161	0.000627	CcSEcCtD
Rifaximin—Shock—Doxorubicin—stomach cancer	0.000161	0.000626	CcSEcCtD
Rifaximin—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	0.00016	0.00741	CbGpPWpGaD
Rifaximin—Nervous system disorder—Doxorubicin—stomach cancer	0.00016	0.000624	CcSEcCtD
Rifaximin—Rash—Capecitabine—stomach cancer	0.00016	0.000622	CcSEcCtD
Rifaximin—Insomnia—Epirubicin—stomach cancer	0.000159	0.000622	CcSEcCtD
Rifaximin—Dermatitis—Capecitabine—stomach cancer	0.000159	0.000622	CcSEcCtD
Rifaximin—Headache—Capecitabine—stomach cancer	0.000159	0.000618	CcSEcCtD
Rifaximin—Skin disorder—Doxorubicin—stomach cancer	0.000158	0.000618	CcSEcCtD
Rifaximin—Hyperhidrosis—Doxorubicin—stomach cancer	0.000158	0.000615	CcSEcCtD
Rifaximin—Dyspnoea—Epirubicin—stomach cancer	0.000157	0.000613	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000157	0.00726	CbGpPWpGaD
Rifaximin—Anorexia—Doxorubicin—stomach cancer	0.000156	0.000607	CcSEcCtD
Rifaximin—Nausea—Docetaxel—stomach cancer	0.000155	0.000606	CcSEcCtD
Rifaximin—Feeling abnormal—Methotrexate—stomach cancer	0.000155	0.000606	CcSEcCtD
Rifaximin—Gastrointestinal pain—Methotrexate—stomach cancer	0.000154	0.000601	CcSEcCtD
Rifaximin—Decreased appetite—Epirubicin—stomach cancer	0.000153	0.000598	CcSEcCtD
Rifaximin—Hypotension—Doxorubicin—stomach cancer	0.000152	0.000595	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—CPSF1—stomach cancer	0.000152	0.00705	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EXOSC5—stomach cancer	0.000152	0.00705	CbGpPWpGaD
Rifaximin—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000152	0.000594	CcSEcCtD
Rifaximin—Fatigue—Epirubicin—stomach cancer	0.000152	0.000593	CcSEcCtD
Rifaximin—Constipation—Epirubicin—stomach cancer	0.000151	0.000588	CcSEcCtD
Rifaximin—Pain—Epirubicin—stomach cancer	0.000151	0.000588	CcSEcCtD
Rifaximin—Nausea—Capecitabine—stomach cancer	0.00015	0.000586	CcSEcCtD
Rifaximin—Urticaria—Methotrexate—stomach cancer	0.00015	0.000584	CcSEcCtD
Rifaximin—Abdominal pain—Methotrexate—stomach cancer	0.000149	0.000581	CcSEcCtD
Rifaximin—Body temperature increased—Methotrexate—stomach cancer	0.000149	0.000581	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000149	0.00058	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—POLR3K—stomach cancer	0.000148	0.00684	CbGpPWpGaD
Rifaximin—Insomnia—Doxorubicin—stomach cancer	0.000148	0.000576	CcSEcCtD
Rifaximin—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.000145	0.00673	CbGpPWpGaD
Rifaximin—Dyspnoea—Doxorubicin—stomach cancer	0.000145	0.000567	CcSEcCtD
Rifaximin—Feeling abnormal—Epirubicin—stomach cancer	0.000145	0.000567	CcSEcCtD
Rifaximin—Gastrointestinal pain—Epirubicin—stomach cancer	0.000144	0.000562	CcSEcCtD
Rifaximin—Decreased appetite—Doxorubicin—stomach cancer	0.000142	0.000553	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000141	0.000549	CcSEcCtD
Rifaximin—Fatigue—Doxorubicin—stomach cancer	0.000141	0.000549	CcSEcCtD
Rifaximin—Urticaria—Epirubicin—stomach cancer	0.00014	0.000546	CcSEcCtD
Rifaximin—Constipation—Doxorubicin—stomach cancer	0.00014	0.000544	CcSEcCtD
Rifaximin—Pain—Doxorubicin—stomach cancer	0.00014	0.000544	CcSEcCtD
Rifaximin—Abdominal pain—Epirubicin—stomach cancer	0.000139	0.000544	CcSEcCtD
Rifaximin—Body temperature increased—Epirubicin—stomach cancer	0.000139	0.000544	CcSEcCtD
Rifaximin—Hypersensitivity—Methotrexate—stomach cancer	0.000139	0.000541	CcSEcCtD
Rifaximin—Asthenia—Methotrexate—stomach cancer	0.000135	0.000527	CcSEcCtD
Rifaximin—Feeling abnormal—Doxorubicin—stomach cancer	0.000134	0.000524	CcSEcCtD
Rifaximin—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000133	0.00052	CcSEcCtD
Rifaximin—Pruritus—Methotrexate—stomach cancer	0.000133	0.00052	CcSEcCtD
Rifaximin—Hypersensitivity—Epirubicin—stomach cancer	0.00013	0.000507	CcSEcCtD
Rifaximin—Urticaria—Doxorubicin—stomach cancer	0.00013	0.000506	CcSEcCtD
Rifaximin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000129	0.00597	CbGpPWpGaD
Rifaximin—Body temperature increased—Doxorubicin—stomach cancer	0.000129	0.000503	CcSEcCtD
Rifaximin—Abdominal pain—Doxorubicin—stomach cancer	0.000129	0.000503	CcSEcCtD
Rifaximin—Diarrhoea—Methotrexate—stomach cancer	0.000129	0.000503	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—RXRB—stomach cancer	0.000128	0.00593	CbGpPWpGaD
Rifaximin—Asthenia—Epirubicin—stomach cancer	0.000127	0.000493	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—RPL18—stomach cancer	0.000126	0.00582	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPL13—stomach cancer	0.000126	0.00582	CbGpPWpGaD
Rifaximin—Pruritus—Epirubicin—stomach cancer	0.000125	0.000487	CcSEcCtD
Rifaximin—Dizziness—Methotrexate—stomach cancer	0.000125	0.000486	CcSEcCtD
Rifaximin—Diarrhoea—Epirubicin—stomach cancer	0.000121	0.000471	CcSEcCtD
Rifaximin—Hypersensitivity—Doxorubicin—stomach cancer	0.00012	0.000469	CcSEcCtD
Rifaximin—Vomiting—Methotrexate—stomach cancer	0.00012	0.000467	CcSEcCtD
Rifaximin—Rash—Methotrexate—stomach cancer	0.000119	0.000463	CcSEcCtD
Rifaximin—Dermatitis—Methotrexate—stomach cancer	0.000119	0.000463	CcSEcCtD
Rifaximin—Headache—Methotrexate—stomach cancer	0.000118	0.00046	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—RPS21—stomach cancer	0.000117	0.00542	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS15—stomach cancer	0.000117	0.00542	CbGpPWpGaD
Rifaximin—Asthenia—Doxorubicin—stomach cancer	0.000117	0.000457	CcSEcCtD
Rifaximin—Dizziness—Epirubicin—stomach cancer	0.000117	0.000455	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—SNRPB—stomach cancer	0.000115	0.00534	CbGpPWpGaD
Rifaximin—Pruritus—Doxorubicin—stomach cancer	0.000115	0.00045	CcSEcCtD
Rifaximin—Vomiting—Epirubicin—stomach cancer	0.000112	0.000437	CcSEcCtD
Rifaximin—Nausea—Methotrexate—stomach cancer	0.000112	0.000437	CcSEcCtD
Rifaximin—Diarrhoea—Doxorubicin—stomach cancer	0.000112	0.000435	CcSEcCtD
Rifaximin—Rash—Epirubicin—stomach cancer	0.000111	0.000434	CcSEcCtD
Rifaximin—Dermatitis—Epirubicin—stomach cancer	0.000111	0.000433	CcSEcCtD
Rifaximin—Headache—Epirubicin—stomach cancer	0.00011	0.000431	CcSEcCtD
Rifaximin—Dizziness—Doxorubicin—stomach cancer	0.000108	0.000421	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—SMAD4—stomach cancer	0.000107	0.00495	CbGpPWpGaD
Rifaximin—Nausea—Epirubicin—stomach cancer	0.000105	0.000408	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—RORA—stomach cancer	0.000104	0.0048	CbGpPWpGaD
Rifaximin—Vomiting—Doxorubicin—stomach cancer	0.000104	0.000405	CcSEcCtD
Rifaximin—Rash—Doxorubicin—stomach cancer	0.000103	0.000401	CcSEcCtD
Rifaximin—Dermatitis—Doxorubicin—stomach cancer	0.000103	0.000401	CcSEcCtD
Rifaximin—Headache—Doxorubicin—stomach cancer	0.000102	0.000399	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—DNMT3B—stomach cancer	9.72e-05	0.00449	CbGpPWpGaD
Rifaximin—Nausea—Doxorubicin—stomach cancer	9.69e-05	0.000378	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—RPL15—stomach cancer	9.53e-05	0.00441	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	9.49e-05	0.00439	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	9.37e-05	0.00433	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RARB—stomach cancer	9.27e-05	0.00429	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS26—stomach cancer	8.89e-05	0.00411	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HSPB1—stomach cancer	7.77e-05	0.00359	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	7.69e-05	0.00356	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS19—stomach cancer	7.56e-05	0.0035	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARG—stomach cancer	7.45e-05	0.00345	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—DNMT1—stomach cancer	7.22e-05	0.00334	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HSPA8—stomach cancer	7.12e-05	0.00329	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	6.9e-05	0.00319	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—SERPINE1—stomach cancer	6.72e-05	0.00311	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS6—stomach cancer	6.68e-05	0.00309	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPP2R1A—stomach cancer	5.56e-05	0.00257	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SMAD4—stomach cancer	5.16e-05	0.00239	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ERCC2—stomach cancer	4.71e-05	0.00218	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—MYC—stomach cancer	4.25e-05	0.00197	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTT1—stomach cancer	4.13e-05	0.00191	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	4.09e-05	0.00189	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	3.92e-05	0.00181	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARG—stomach cancer	3.59e-05	0.00166	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—SERPINE1—stomach cancer	3.23e-05	0.00149	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTP1—stomach cancer	2.87e-05	0.00133	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	2.83e-05	0.00131	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTM1—stomach cancer	2.63e-05	0.00122	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	2.6e-05	0.0012	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ACAD8—stomach cancer	2.46e-05	0.00114	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GMPR2—stomach cancer	2.2e-05	0.00102	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—MAPK3—stomach cancer	2.1e-05	0.000973	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—MYC—stomach cancer	2.05e-05	0.000946	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.01e-05	0.000929	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—IDH3B—stomach cancer	2.01e-05	0.000929	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.87e-05	0.000863	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.87e-05	0.000863	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PGLS—stomach cancer	1.66e-05	0.00077	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—BLVRB—stomach cancer	1.66e-05	0.00077	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.59e-05	0.000734	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CKB—stomach cancer	1.42e-05	0.000654	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.42e-05	0.000654	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FBP1—stomach cancer	1.42e-05	0.000654	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA1—stomach cancer	1.42e-05	0.000654	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLIN2—stomach cancer	1.33e-05	0.000615	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA2—stomach cancer	1.29e-05	0.000598	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NT5E—stomach cancer	1.26e-05	0.000583	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PGAM1—stomach cancer	1.26e-05	0.000583	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.2e-05	0.000556	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLCE1—stomach cancer	1.2e-05	0.000556	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UMPS—stomach cancer	1.15e-05	0.000533	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PDHA1—stomach cancer	1.07e-05	0.000496	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ECHS1—stomach cancer	1.07e-05	0.000496	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TYMP—stomach cancer	1.01e-05	0.000466	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FADS1—stomach cancer	1.01e-05	0.000466	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SREBF2—stomach cancer	9.44e-06	0.000437	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—RORA—stomach cancer	9.33e-06	0.000431	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDOB—stomach cancer	8.74e-06	0.000404	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALOX5—stomach cancer	8.13e-06	0.000376	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DPYD—stomach cancer	8e-06	0.00037	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTT1—stomach cancer	7.07e-06	0.000327	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.99e-06	0.000323	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.8e-06	0.000314	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ENO1—stomach cancer	6.63e-06	0.000306	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CD44—stomach cancer	5.88e-06	0.000272	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5e-06	0.000231	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTP1—stomach cancer	4.9e-06	0.000227	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMOX1—stomach cancer	4.83e-06	0.000224	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TYMS—stomach cancer	4.56e-06	0.000211	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTM1—stomach cancer	4.5e-06	0.000208	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ERCC2—stomach cancer	4.23e-06	0.000196	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MTHFR—stomach cancer	3.98e-06	0.000184	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CAV1—stomach cancer	3.67e-06	0.00017	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APOA1—stomach cancer	3.66e-06	0.000169	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARG—stomach cancer	3.23e-06	0.000149	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—stomach cancer	2.9e-06	0.000134	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NOS3—stomach cancer	2.78e-06	0.000128	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—stomach cancer	2.54e-06	0.000117	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.56e-06	7.22e-05	CbGpPWpGaD
